Sean Arenson joined Keker, Van Nest & Peters in the fall of 2016 after clerking for the Honorable Raymond C. Fisher on the Ninth Circuit Court of Appeals.
A Sacramento native, Mr. Arenson graduated from Yale Law School where he was an editor of the Yale Law Journal and Editor-in-Chief of the Yale Journal of Health Policy, Law and Ethics. Prior to attending law school, Mr. Arenson studied health economics and policy as a Marshall Scholar at the London School of Economics and the University of Cambridge and worked as a management consultant at McKinsey & Company.
We represent Genentech in a federal trade secret theft lawsuit alleging that former Genentech scientists, several of whom have also been charged criminally by the Department of Justice, stole confidential and proprietary information to help a foreign company develop biosimilar versions of Genentech medicines.
We are defending San Francisco-based Coinbase in a putative class action alleging insider trading and violations of the Commodities Exchange Act and Business & Professions Code Section 17200 in connection with the launch of a new digital currency. We filed a successful motion to dismiss all but one of the Plaintiffs’ claims with prejudice, and in December 2020, the Ninth Circuit Court of Appeals reversed a trial court order denying a motion to compel arbitration of the sole remaining claim in the case and requiring the plaintiffs to individually arbitrate that claim.
The issues at stake in the case illustrate the growing importance of trade secrets protection to life sciences companies and the IP professionals who serve them. Read more
Genentech reaches a settlement agreement with JHL Biotech, which sees the latter cease development of biosimilars to Genentech’s products. Read more
Taiwan’s JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of a deal to end high-stakes trade secrets litigation. Read more